NCT03664999View on ClinicalTrials.gov

Serum Immunologic Markers Levels in During the Delivery

CompletedOBSERVATIONAL
Enrollment

57

Participants

Timeline

Start Date

September 8, 2018

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions
Immunologic Markers
Interventions
DIAGNOSTIC_TEST

Blood sampling

differences between dynamics of the complement components C1 inhibitor, C1 inhibitor activity, C3, C4 during the labour in a group of women with physiologic pregnancy and in a group with a risk of complications (pre-eclampsia, HELLP syndrome, placenta praevia, placental abruption, IUGR, previous post partum hypotony).

Trial Locations (1)

62500

University Hospital Brno, Brno

All Listed Sponsors
lead

Brno University Hospital

OTHER

NCT03664999 - Serum Immunologic Markers Levels in During the Delivery | Biotech Hunter | Biotech Hunter